Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Jan 23, 2024 (filed on Feb 26, 2024)Insider Name:Mika ThomasOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,666Price:--
-
Jan 23, 2024 (filed on Feb 26, 2024)Insider Name:Jacob HaroldOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:6,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Schroeder MariaOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Ferguson MichaelOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,666Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Goldstein Martin MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Cassirer AuroraOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-15,000Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-10,000Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-2,500Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-1,875Price:--
Filings by filing date
-
Jan 23, 2024 (filed on Feb 26, 2024)Insider Name:Mika ThomasOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,666Price:--
-
Jan 23, 2024 (filed on Feb 26, 2024)Insider Name:Jacob HaroldOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:6,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Schroeder MariaOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Ferguson MichaelOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,666Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Goldstein Martin MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Cassirer AuroraOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-15,000Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-10,000Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-2,500Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-1,875Price:--
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 525 Executive Blvd ELMSFORD NY 10523 |
Tel: | N/A |
Website: | https://nanovibronix.com |
IR: | See website |
Key People | ||
Brian M. Murphy Chief Executive Officer, Director | Stephen Russell Brown Chief Financial Officer | Harold Jacob Chief Medical Officer, Director |
Business Overview |
NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. |
Financial Overview |
For the fiscal year ended 31 December 2023, NanoVibronix Inc revenues increased from $752K to $2.3M. Net loss decreased 32% to $3.7M. Revenues reflect United States segment increase from $710K to $2.2M, Europe segment increase from $25K to $101K. Lower net loss reflects Selling and Marketing - Balancing value decrease of 11% to $836K (expense), Research & development decrease of 35% to $179K (expense). |
Employees: | 10 as of Apr 8, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | N/A |
Annual revenue (TTM): | $2.28M as of Dec 31, 2023 |
EBITDA (TTM): | -$3.44M as of Dec 31, 2023 |
Net annual income (TTM): | -$3.71M as of Dec 31, 2023 |
Free cash flow (TTM): | -$3.60M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 2,784,354 as of Apr 8, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |